AR
Arvinas, Inc.
ARVN · NASDAQ
$9.08 -1.63% (-$0.15)
1M +4.45%
Market Cap $605.9M
P/E Ratio 65.15x
Div. Yield -
ROE 1.91%
Piotroski F-Score Moderate
6/9Valuation
27 /100
Expensive P/E 65.15x
EV/EBITDA 179.16x
P/S 1.91x
Growth
78 /100
Growing Rev. growth 25.96%
Book val. growth 8.43%
EPS growth N/A
Profitability
25 /100
Weak Gross margin 96.43%
Net margin 2.94%
Op. margin 4.45%
Quality
10 /100
Poor ROIC 2.18%
ROE 1.91%
ROA 1.38%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 7.91x
Net debt/EBITDA -29.76x
Stability
17 /100
Unstable Beta 1.74x
Rev. volatility 149.04%
EPS volatility 46.61%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ARVN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Randy Teel
Employees
246
Headquarters
New Haven
Evenimente viitoare
04 NOV.
Earnings
Upcoming earnings report